Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.7 GBX | -0.24% | +4.45% | +2.76% |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Sales 2022 | 18.69M 23.38M | Sales 2023 | -39.79M -49.77M | Capitalization | 992M 1.24B |
---|---|---|---|---|---|
Net income 2022 | 8M 10.01M | Net income 2023 | -56M -70.04M | EV / Sales 2022 | 57.1 x |
Net cash position 2022 | 276K 345K | Net cash position 2023 | 11K 13.76K | EV / Sales 2023 | -24.9 x |
P/E ratio 2022 |
122
x | P/E ratio 2023 |
-17.7
x | Employees | 1,208 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.81% |
Latest transcript on Syncona Limited
1 day | -0.63% | ||
1 week | +3.46% | ||
Current month | +2.11% | ||
1 month | +2.61% | ||
3 months | +6.44% | ||
6 months | -0.32% | ||
Current year | +1.78% |
Managers | Title | Age | Since |
---|---|---|---|
Annabel Clark
IRC | Investor Relations Contact | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 22-01-31 | |
Virginia Holmes
BRD | Director/Board Member | 64 | 20-12-31 |
Kemal Malik
BRD | Director/Board Member | 61 | 20-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 126.8 | -0.16% | 84 845 |
24-04-25 | 127 | +0.79% | 217,073 |
24-04-24 | 126 | +1.61% | 1,152,173 |
24-04-23 | 124 | 0.00% | 837,331 |
24-04-22 | 124 | +2.14% | 377,097 |
Delayed Quote London S.E., April 26, 2024 at 03:34 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.78% | 1.04B | |
+15.59% | 74.61B | |
+50.14% | 16.66B | |
+3.93% | 15.56B | |
+6.17% | 13.66B | |
-1.50% | 12.18B | |
+9.67% | 12.06B | |
+5.32% | 10.96B | |
+31.64% | 9.95B | |
-2.13% | 9.59B |
- Stock Market
- Equities
- BACT Stock